Molecular Partners (MOLN) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free MOLN Stock Alerts $3.85 -0.03 (-0.77%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Molecular Partners Short Interest DataCurrent Short Volume47,900 sharesPrevious Short Volume49,000 sharesChange Vs. Previous Month-2.24%Dollar Volume Sold Short$201,180.00Short Interest Ratio / Days to Cover9.8Last Record DateMarch 31, 2024Outstanding Shares36,369,000 sharesPercentage of Shares Shorted0.13%Today's Trading Volume523 sharesAverage Trading Volume13,644 sharesToday's Volume Vs. Average4% Short Selling Molecular Partners ? Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMOLN Short Interest Over TimeMOLN Days to Cover Over TimeMOLN Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Molecular Partners Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202447,900 shares $201,180.00 -2.2%N/A9.8 $4.20 3/15/202449,000 shares $194,040.00 -12.5%N/A3.7 $3.96 2/29/202456,000 shares $240,800.00 -7.6%N/A4.1 $4.30 2/15/202460,600 shares $282,093.00 +3.6%N/A4.5 $4.66 1/31/202458,500 shares $279,630.00 -13.7%N/A4.4 $4.78 1/15/202467,800 shares $323,406.00 +1,132.7%N/A4.9 $4.77 Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 12/31/20235,500 shares $22,989.45 -11.3%N/A0.4 $4.18 12/15/20236,200 shares $26,102.00 -39.2%N/A2.4 $4.21 11/30/202310,200 shares $42,840.00 +117.0%N/A2.6 $4.20 11/15/20234,700 shares $20,774.00 -4.1%N/A1 $4.42 10/31/20234,900 shares $17,297.00 +2.1%N/A0.9 $3.53 10/15/20234,800 shares $20,884.32 -34.3%N/A1 $4.35 9/30/20237,300 shares $30,222.00 -73.1%N/A1.6 $4.14 9/15/202327,100 shares $123,576.00 +173.7%N/A6 $4.56 8/31/20239,900 shares $59,301.00 +135.7%N/A3.5 $5.99 8/15/20234,200 shares $24,822.00 +23.5%N/A2.1 $5.91 7/31/20233,400 shares $20,349.00 +21.4%N/A2.6 $5.99 7/15/20232,800 shares $18,312.00 -46.2%N/A2.3 $6.54 6/30/20235,200 shares $32,344.00 -3.7%N/A4 $6.22 6/15/20235,400 shares $35,748.00 +54.3%N/A4.2 $6.62 5/31/20233,500 shares $22,470.00 -31.4%N/A2.1 $6.42 5/15/20235,100 shares $33,762.51 -42.7%N/A3.6 $6.62 4/30/20238,900 shares $58,651.00 -60.4%N/A4.9 $6.59 4/15/202322,500 shares $146,925.00 +9.2%N/A10.2 $6.53 3/31/202320,600 shares $124,380.74 +32.1%N/A9.4 $6.04 3/15/202315,600 shares $91,416.00 +2.6%N/A6.2 $5.86 2/28/202315,200 shares $95,000.00 No ChangeN/A4.8 $6.25 2/15/202315,200 shares $97,584.00 -2.6%N/A4.5 $6.42 1/31/202315,600 shares $100,620.00 -1.3%N/A3 $6.45 1/15/202315,800 shares $107,484.24 +22.5%N/A2.8 $6.80 12/30/202212,900 shares $84,495.00 +10.3%N/A1.7 $6.55 12/15/202211,700 shares $80,028.00 -14.0%N/A1.4 $6.84 11/30/202213,600 shares $87,040.00 +9.7%N/A1.5 $6.40 11/15/202212,400 shares $86,056.00 -2.4%N/A1.3 $6.94 10/31/202212,700 shares $79,122.27 -7.3%N/A1.3 $6.23 10/15/202213,700 shares $83,433.00 -12.7%N/A1.5 $6.09 9/30/202215,700 shares $105,033.00 -20.7%N/A1.7 $6.69 9/15/202219,800 shares $124,938.00 -26.4%N/A1.9 $6.31 8/31/202226,900 shares $157,634.00 -9.4%N/A2 $5.86 8/15/202229,700 shares $201,663.00 -34.3%N/A1.6 $6.79top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… MOLN Short Interest - Frequently Asked Questions What is Molecular Partners' current short interest? Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 47,900 shares of MOLN short. Learn More on Molecular Partners' current short interest. What is a good short interest ratio for Molecular Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 10.0. Learn More on Molecular Partners's short interest ratio. Is Molecular Partners' short interest increasing or decreasing? Molecular Partners saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 47,900 shares, a drop of 2.2% from the previous total of 49,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Molecular Partners' short interest compare to its competitors? Here is how the short interest of companies compare to Molecular Partners: Cellectis S.A. (1.22%), DBV Technologies S.A. (0.28%), Omega Therapeutics, Inc. (19.78%), Agenus Inc. (227.78%), Zura Bio Limited (3.32%), Vaxart, Inc. (9.72%), Karyopharm Therapeutics Inc. (19.94%), BioAtla, Inc. (11.62%), INmune Bio, Inc. (13.03%), Cardiol Therapeutics Inc. (0.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Partners stock? Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Partners? A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further. How often is Molecular Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Cellectis Short Squeeze DBV Technologies Short Squeeze Omega Therapeutics Short Squeeze Agenus Short Squeeze Zura Bio Short Squeeze Vaxart Short Squeeze Karyopharm Therapeutics Short Squeeze BioAtla Short Squeeze INmune Bio Short Squeeze Cardiol Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MOLN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryGreat Crypto BullWeiss RatingsThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersBiden out June 13; Kamala won’t replace him?Paradigm Press